SCYNEXIS Stock

SCYNEXIS Shareholder Yield

The Shareholder Yield of SCYNEXIS (SCYX) as of Aug 4, 2026 is 0.18 %. In the previous year, Shareholder Yield was 0.13 % — a change of 33.33% (higher).

Shareholder Yield

0.18 %

YoY

33.33%

Last updated:

Shareholder Yield of SCYNEXIS is 2026 0.18 % . Shareholder Yield of SCYNEXIS was 2025 0.13 % . It decreases by 33.33% higher compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Shareholder Yield of SCYNEXIS is 0.18 % in 2026.

Shareholder Yield of SCYNEXIS changed from 0.13 % to 0.18 %, representing a 33.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Shareholder Yield SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Shareholder yield combines dividend yield and buyback yield to show the total cash return to shareholders. It captures both dividends and share repurchases.

To evaluate Shareholder Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Shareholder Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Shareholder Yield's SCYNEXIS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — SCYNEXIS

All Key Metrics — SCYNEXIS